Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Industry News

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

September 28, 2015

News Daily News

现实中 LVAD 在被认为无法行 PCI 的危重患者中的使用颇具结局前景

L.A. McKeown

August 24, 2015

News Daily News

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

L.A. McKeown

August 24, 2015

News Daily News

El Uso de DAVI en el Mundo Real es Prometedor en Pacientes Considerados, de Otra Forma, Demasiados Enfermos para ser Sometidos a una PCI

L.A. McKeown

August 24, 2015

Presentation

Percutaneous LVAD for High-Risk PCIs:Real-World vs Clinical-Trial Experience

Presenter: Mauricio G. Cohen

August 21, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

Presentation CATCH-UP 2015

Right Heart Failure After LVAD

Presenter: Maryjane Farr

April 25, 2015

Presentation CATCH-UP 2015

Palliative Care - End of life care for LVAD patients

Presenter: Shunichi Nakagawa

April 25, 2015

Presentation CATCH-UP 2015

Adult Congenital Heart Disease: Role of LVAD Therapy

Presenter: Paul J. Chai

April 25, 2015

Presentation CATCH-UP 2015

Should We Treat VT in LVAD Patients? Who Needs an ICD?

Presenter: Paolo C. Colombo

April 24, 2015

Presentation CATCH-UP 2015

LVAD State of the Field

Presenter: Paolo C. Colombo

April 24, 2015

Presentation CATCH-UP 2015

Early Post-operative Right Ventricular Failure following LVAD Implantation

Presenter: Alan Gaffney

April 24, 2015

Presentation CATCH-UP 2015

Hematology on the LVAD Team

Presenter: Andrew Eisenberger

April 24, 2015

Presentation

Trends in the Use of Percutaneous Left Ventricular Assist Devices (LVADs)

Presenter: R. Khera

April 08, 2015

News Daily News

Study Finds Exponential Growth in Percutaneous LVAD Use

April 08, 2015

Presentation TVT 2012

Transcatheter Treatment of LVAD-associated Aortic Regurgitation

Presenter: 136460|Atman Shah

June 02, 2012

Advertisement

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

现实中 LVAD 在被认为无法行 PCI 的危重患者中的使用颇具结局前景

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

El Uso de DAVI en el Mundo Real es Prometedor en Pacientes Considerados, de Otra Forma, Demasiados Enfermos para ser Sometidos a una PCI

Percutaneous LVAD for High-Risk PCIs:Real-World vs Clinical-Trial Experience

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

Right Heart Failure After LVAD

Palliative Care - End of life care for LVAD patients

Adult Congenital Heart Disease: Role of LVAD Therapy

Should We Treat VT in LVAD Patients? Who Needs an ICD?

LVAD State of the Field

Early Post-operative Right Ventricular Failure following LVAD Implantation

Hematology on the LVAD Team

Trends in the Use of Percutaneous Left Ventricular Assist Devices (LVADs)

Study Finds Exponential Growth in Percutaneous LVAD Use

Transcatheter Treatment of LVAD-associated Aortic Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content